Uwe Schlomann

发表

ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP‐9 expression and transendothelial migration in breast cancer cells

C. Nimsky, R. Kamm, Ran Li, 2018, International journal of cancer.

ADAM8 signaling drives neutrophil migration and ARDS severity

N. Suttorp, A. Zarbock, A. Margraf, 2022, JCI insight.

Degradome of soluble ADAM10 and ADAM17 metalloproteases

D. Schmidt-Arras, S. Rose-John, A. Tholey, 2019, Cellular and Molecular Life Sciences.

Progressive Loss of Striatal Neurons Causes Motor Dysfunction in MND2 Mutant Mice and Is Not Prevented by Bcl-2

M. Meisler, H. Jockusch, P. Heimann, 2002, Experimental Neurology.

Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration

H. Jockusch, Shunsuke Yamamoto, J. Bartsch, 2000, The Journal of Neuroscience.

Elevated expression of membrane type 1 metalloproteinase (MT1‐MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system

H. Jockusch, J. Frey, M. Staege, 2000, FEBS letters.

The stimulation of dendrite growth by Sema3A requires integrin engagement and focal adhesion kinase

R. Fässler, A. Püschel, J. Schwamborn, 2009, Journal of Cell Science.

Axonal growth towards Xenopus skin in vitro is mediated by matrix metalloproteinase activity

M. Ward, S. Lynham, Ning Zhu, 2013, The European journal of neuroscience.

ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.

C. Nimsky, A. Zarbock, E. Slater, 2019, Clinical science.

Altered Heparan Sulfate Structure in Mice with Deleted NDST3 Gene Function*

J. Esko, Yi-Wun Pan, L. Lewejohann, 2008, Journal of Biological Chemistry.

The Metalloprotease Disintegrin ADAM8

H. Jockusch, D. Wildeboer, D. Zeuschner, 2002, The Journal of Biological Chemistry.

The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.

C. Culmsee, C. Nimsky, O. Schilling, 2015, Neuro-oncology.

Metalloproteinases ADAM12 and MMP‐14 are associated with cavernous sinus invasion in pituitary adenomas

C. Nimsky, Barbara Carl, J. Bartsch, 2016, International journal of cancer.

ADAM8 as a drug target in Pancreatic Cancer

Miles A. Miller, D. Lauffenburger, Randal R Ketchem, 2015, Nature Communications.

The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness

Miriam H. A. Bopp, C. Nimsky, E. P. von Strandmann, 2022, Frontiers in Oncology.

Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays

T. Tuccinardi, E. Nuti, A. Rossello, 2019, Biological chemistry.

ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9

Miles A. Miller, E. Slater, E. P. von Strandmann, 2022, International journal of molecular sciences.

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis

M. Duffy, E. McDermott, I. Georgakoudi, 2013, EMBO molecular medicine.

ADAM9 Inhibition Increases Membrane Activity of ADAM10 and Controls α-Secretase Processing of Amyloid Precursor Protein*

Miles A. Miller, D. Lauffenburger, B. de Strooper, 2011, The Journal of Biological Chemistry.

Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration

C. Nimsky, C. Hogstrand, S. Wernhart, 2016, BioMetals.

ADAM8/MS2/CD156a

D. Wildeboer, Andrea Rittger, J. Bartsch, 2005 .

A colorimetric-based amplification system for proteinases including MMP2 and ADAM8.

S. Rakow, G. Koller, J. Bartsch, 2015, Analytical biochemistry.

ADAM 8 as a drug target in pancreatic cancer

Miles A. Miller, D. Lauffenburger, Randal R Ketchem, 2015 .

Synthesis and biological evaluation of analogues of the potent ADAM8 inhibitor cyclo(RLsKDK) for the treatment of inflammatory diseases and cancer metastasis.

M. Brimble, Anaïs F. M. Noisier, J. Bartsch, 2016, Bioorganic & medicinal chemistry.

Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method.

Miles A. Miller, D. Lauffenburger, J. Bartsch, 2017, Methods in molecular biology.

Degradome of soluble ADAM10 and ADAM17 metalloproteases

D. Schmidt-Arras, S. Rose-John, A. Tholey, 2019, Cellular and Molecular Life Sciences.

ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.

G. Koller, J. Bartsch, S. Naus, 2009, Current pharmaceutical design.

ADAM8 affects glioblastoma progression by regulating osteopontin-mediated angiogenesis

Miriam H. A. Bopp, C. Nimsky, A. Pagenstecher, 2020, Biological chemistry.

The stimulation of dendrite growth by Sema3A requires integrin engagement and focal adhesion kinase

R. Fässler, A. Püschel, J. Schwamborn, 2009, Journal of Cell Science.